Phio Pharmaceuticals Expands Global Patent Portfolio with New Milestones

Phio Pharmaceuticals (NASDAQ:PHIO) has received three notices of allowance and one patent grant decision for its INTASYL® compounds, expanding intellectual property protection in the United States, Canada, and Japan. The company now holds 54 issued patents covering various aspects of its gene silencing platform.

By Fiona Craig Wed, July 15, 2026 at 6:06 PM GMT+3 2 min read · Yahoo Finance · July 15, 2026, 15:06 UTC

Phio Pharmaceuticals Expands Global Patent Portfolio with New Milestones

Tickers: $PHIO

Topics: ip_protection patents pharmaceuticals

Read the full article at Yahoo Finance

More World news

Nvidia CEO Jensen Huang Resigns Amid Investigation and Personal Allegations Motley Fool · November 12, 2026, 17:20 UTC
Argus Research Upgrades Republic Services to Buy Seeking Alpha · November 12, 2026, 17:16 UTC
Moderna Shares Decline Following Analyst Day Projections and Future Cost Concerns Motley Fool · November 12, 2026, 17:13 UTC
United Airlines Restricts AI Agent Access to Booking Systems Due to Cybersecurity and Regulatory Concerns TechCrunch · November 12, 2026, 17:17 UTC
Global Payments Shares Drop 12% Following Reports Private Equity Firms Abandoned Takeover Bid Seeking Alpha · November 12, 2026, 17:14 UTC
Nvidia Appoints Colette Kress as Interim CEO Following Jensen Huang's Resignation CNBC · November 12, 2026, 16:59 UTC
Brookfield Corporation Reports Strong Third Quarter Earnings Growth and Increased Share Buybacks Motley Fool · November 12, 2026, 17:08 UTC
Franco-Nevada Reports Q3 2026 Revenue Growth Driven by Higher Gold and Oil Prices Motley Fool · November 12, 2026, 17:10 UTC
Stratasys Reports Q3 2026 Revenue Growth Driven by Aerospace and Defense Demand Motley Fool · November 12, 2026, 17:11 UTC
Jim Cramer Advises Profit-Taking Following Jensen Huang's Resignation at Nvidia CNBC · November 12, 2026, 16:59 UTC